Mark Sabag
2018
Compensation breakdown
Non-Equity Incentive Plan | $1,090,467 |
---|---|
Option Awards | $866,685 |
Salary | $605,749 |
Stock Awards | $2,254,711 |
Other | $427,724 |
Total | $5,245,336 |
Sabag received $2.3M in stock awards, accounting for 43% of the total pay in 2018.
Sabag also received $1.1M in non-equity incentive plan, $866.7K in option awards, $605.7K in salary and $427.7K in other compensation.
Rankings
In 2018, Mark Sabag's compensation ranked 1,891st out of 14,244 executives tracked by ExecPay. In other words, Sabag earned more than 86.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,891 out of 14,244 | 87th |
Division Manufacturing | 678 out of 5,765 | 88th |
Major group Chemicals And Allied Products | 223 out of 2,128 | 90th |
Industry group Drugs | 176 out of 1,817 | 90th |
Industry Pharmaceutical Preparations | 134 out of 1,391 | 90th |
Sabag's colleagues
We found four more compensation records of executives who worked with Mark Sabag at Teva Pharmaceutical Industries in 2018.
2018
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2018
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2018
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2018
Michael McClellan
Teva Pharmaceutical Industries